Results 241 to 250 of about 2,360,810 (305)

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

Next‐Generation Glutamine Synthetase Expression Vector for Therapeutic Protein Manufacturing Using CHO Cells

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT The glutamine synthetase expression system is widely used for therapeutic protein biomanufacturing in Chinese hamster ovary (CHO) cells. Here, we present the design of an enhanced glutamine synthetase vector for generating CHOK1SV GS‐KO stable pools that produce recombinant proteins at multigram‐per‐liter levels. We first developed a synthetic
Yusuf B. Johari   +11 more
wiley   +1 more source

Dialogue, inclusion, and adaptation in a remote marine sanctuary: evidence from Flower Garden Banks. [PDF]

open access: yesEnviron Manage
Dunning KH   +15 more
europepmc   +1 more source

Commercial Banking in the Sixties

The Journal of Finance, 1961
IF THE TRENDS EMERGING in the late 1950's and in 1960 are not reversed by marked changes in economic conditions or tax and regulatory policy, the commercial banks will not be able to play as important a role in financing the 1960's as they have done in years past.
openaire   +1 more source

Home - About - Disclaimer - Privacy